|
|
|
|
|
by xattt
1038 days ago
|
|
Yes, but with machine learning this time! > This approach represents an automated and accessible screening strategy for LV systolic dysfunction, particularly in low-resource settings. If the low-resource setting means there is no one to interpret a 12-lead that suggests LV dysfunction, what are the chances the individual will have reliable access to an echo or, further down the line, an ACEi to slow remodelling? |
|
Why would a human be needed to interpret anything, if the detection can be done by software?
It may be legally required, but that can change with the stroke of a pen.
As for getting access to an echo, why wouldn't it be possible to also have that done by software?
Then for ACEi, if people already can easily purchase illegal drugs, why do you think they won't be able to buy ACI?
In a "low resource setting", I think enforcing drug laws may also be affected by the "low resources": people who want to avoid heart problems may be strongly incentivized to disregard the already poorly enforced laws to acquire whatever they need thay may increase their lifespan.